Skip to content
Trial Eligibility
Menu

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

NCT07032545

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Obesity can pose significant challenges to maintaining long-term health in cancer survivors by increasing their risk of cancer coming back. Eating a healthy diet is an important way to help manage weight and improve overall health. Broccoli microgreens (BMG) are young broccoli plants packed with nutrients, and research suggests they may help prevent cancer. Previous studies in mice showed that BMG can improve gut health and metabolism, leading to better health outcomes in obese animals.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Obesity and Overweight
  • Breast Cancer Survivorship

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
Any age
Sex
Female
Healthy volunteers
Not accepted
Sponsor
University of Maryland, Baltimore
Last updated on ClinicalTrials.gov
December 23, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center · Baltimore, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.